US 10080743
Isoxazole derivatives as FXR agonists and methods of use thereof
granted A61KA61K31/42A61K31/422
Quick answer
US patent 10080743 (Isoxazole derivatives as FXR agonists and methods of use thereof) held by Enanta Pharmaceuticals, Inc. expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/42, A61K31/422